Verbatim report of proceedings

Wednesday, 18 September 2024 - Strasbourg

4.3. Objection pursuant to Rule 115(2) and (3), and (4)(c): Maximum residue levels for cyproconazole (B10-0021/2024) (vote)

  President. – The next vote is on the objection to maximum residue levels for cyproconazole (See minutes, item 4.3.).

(The vote closed)

(The sitting was suspended at 12:19)

IN THE CHAIR: SOPHIE WILMÈS
Vice-President